Sun/SPARC Glaucoma Drug Approved

A Tube Shunt Fails: What’s Next?

With limited published data to guide us, deciding how to proceed in this situation can be a challenge. Here’s help.

Cataract/Glaucoma Surgeons Suffer CyPASS Withdrawal

Two Unique Glaucoma Drugs Debut

Latanoprostene bunod and netarsudil offer surgeons new options in the battle to effectively lower IOP.

Can Sustained Release Deliver the Goods?

The hope is that sustained-release glaucoma drugs will overcome compliance challenges.

Choosing MIGS (for You and Your Patient)

With more options rapidly appearing, picking the right procedure can be challenging. Here’s help.

Diagnosing Early Glaucoma: Pearls and Pitfalls

In our ongoing attempts to detect the disease at its earliest stages, new technologies are showing promise.

Managing Pseudoexfoliation During Cataract Surgery

Treating Uveitic Glaucoma: What Works?

Because these patients have two conditions, treatment can be a challenge. However, today’s options are improving the prognosis.

Supplements & Glaucoma: Advising Your Patients

Given the popularity of questionable “alternative” treatments, your patients are counting on you to set them straight.